ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up
Crossref DOI link: https://doi.org/10.1007/s00417-017-3748-0
Published Online: 2017-07-25
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Valverde-Megías, Alicia http://orcid.org/0000-0002-6166-114X
Veganzones-de-Castro, Silvia
Donate-López, Juan
Maestro-de-las-Casas, Maria Luisa
Megías-Fresno, Alicia
García-Feijoo, Julián
License valid from 2017-07-25